Recurrent corneal erosion: a comprehensive review
- PMID: 30809089
- PMCID: PMC6376883
- DOI: 10.2147/OPTH.S157430
Recurrent corneal erosion: a comprehensive review
Abstract
Purpose: To comprehensively review the literature regarding recurrent corneal erosion (RCE) and to present treatment options and recommendations for management.
Overview: RCE usually presents with sharp, unilateral pain upon awakening, in an eye with an underlying basement membrane dystrophy, prior ocular trauma, stromal dystrophy or degeneration, or prior surgery for refractive errors, cataracts, or corneal transplantation. Making the correct diagnosis requires a careful slit-lamp examination of both eyes coupled with a high degree of suspicion. Several treatments are commonly used for RCE but new therapies have been introduced recently. Conservative treatment consists of antibiotic and preservative-free lubricating drops, with topical cycloplegics and oral analgesics to control pain. Patients who are unresponsive to these therapies may benefit from therapeutic bandage contact lenses (BCL). Newer therapies include oral matrix metalloproteinase (MMP) inhibitors, blood-derived eye drops, amniotic membrane graft application, and judicious application of topical corticosteroids. Once the epithelium is healed, a course of hypertonic saline solution and/or ointment can be used. Surgical procedures may be performed in patients who fail conservative therapy. Punctal occlusion with plugs increases the tear film volume. Epithelial debridement with diamond burr polishing (DBP), anterior stromal puncture (ASP), or alcohol delamination should be considered in selected patients. DBP can be used for patients with basement membrane dystrophies and is the preferred treatment overall due to a low recurrence rate. ASP can be used for erosions outside the central visual axis. Excimer laser phototherapeutic keratectomy is an attractive option in eyes with central RCE since it precisely removes tissue while preserving corneal transparency. In patients with RCE who are also candidates for refractive surgery, photorefractive keratectomy can be considered.
Summary: Newly introduced therapies for RCE enable therapy to be individualized and lower the recurrence rate.
Keywords: anterior basement membrane dystrophy; corneal abrasion; epithelial basement membrane dystrophy; map-dot-fingerprint dystrophy; recurrent corneal erosion.
Conflict of interest statement
Disclosure Michael Stewart’s disclosures include the following: Allergan: institutional research support; Alkahest: consultant; Bayer: consultant; Regeneron: institutional research support. The other authors report no conflicts of interest in this work.
Figures
References
-
- Hykin PG, Foss AE, Pavesio C, Dart JK. The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye (Lond) 1994;8(Pt 1):35–40. - PubMed
-
- Suri K, Kosker M, Duman F, Rapuano CJ, Nagra PK, Hammersmith KM. Demographic patterns and treatment outcomes of patients with recurrent corneal erosions related to trauma and epithelial and Bowman layer disorders. Am J Ophthalmol. 2013;156(6):1082.e2–1087.e2. - PubMed
-
- Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001;132(1):8–13. - PubMed
-
- Reidy JJ, Paulus MP, Gona S. Recurrent erosions of the cornea: epidemiology and treatment. Cornea. 2000;19(6):767–771. - PubMed
-
- Xu K, Kam KW, Young AL, Jhanji V. Recurrent corneal erosion syndrome. Asia Pac J Ophthalmol (Phila) 2012;1(6):349–354. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
